These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 14660043)

  • 1. Purification of human natural killer cells using a clinical-scale immunomagnetic method.
    Iyengar R; Handgretinger R; Babarin-Dorner A; Leimig T; Otto M; Geiger TL; Holladay MS; Houston J; Leung W
    Cytotherapy; 2003; 5(6):479-84. PubMed ID: 14660043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical scale isolation of T cell-depleted CD56+ donor lymphocytes in children.
    Lang P; Pfeiffer M; Handgretinger R; Schumm M; Demirdelen B; Stanojevic S; Klingebiel T; Köhl U; Kuci S; Niethammer D
    Bone Marrow Transplant; 2002 Mar; 29(6):497-502. PubMed ID: 11960269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.
    McKenna DH; Sumstad D; Bostrom N; Kadidlo DM; Fautsch S; McNearney S; Dewaard R; McGlave PB; Weisdorf DJ; Wagner JE; McCullough J; Miller JS
    Transfusion; 2007 Mar; 47(3):520-8. PubMed ID: 17319835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical-scale production of cGMP compliant CD3/CD19 cell-depleted NK cells in the evolution of NK cell immunotherapy at a single institution.
    Williams SM; Sumstad D; Kadidlo D; Curtsinger J; Luo X; Miller JS; McKenna DH
    Transfusion; 2018 Jun; 58(6):1458-1467. PubMed ID: 29532488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells.
    Nakashima Y; Deie M; Yanada S; Sharman P; Ochi M
    Int J Oncol; 2005 Oct; 27(4):965-71. PubMed ID: 16142312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD56 identifies monocytes and not natural killer cells in rhesus macaques.
    Carter DL; Shieh TM; Blosser RL; Chadwick KR; Margolick JB; Hildreth JE; Clements JE; Zink MC
    Cytometry; 1999 Sep; 37(1):41-50. PubMed ID: 10451505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical-scale single-step CD4(+) and CD8(+) cell depletion for donor innate lymphocyte infusion (DILI).
    Smetak M; Kimmel B; Birkmann J; Schaefer-Eckart K; Einsele H; Wilhelm M; Kunzmann V
    Bone Marrow Transplant; 2008 Apr; 41(7):643-50. PubMed ID: 18037935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and cytolytic activity of Macaca nemestrina natural killer cells isolated from blood and expanded in vitro.
    Shields LE; Sieverkropp AJ; Potter J; Andrews RG
    Am J Primatol; 2006 Aug; 68(8):753-64. PubMed ID: 16847969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of residual T- and B-cell content after immunomagnetic depletion: proposal for flow cytometric analysis and results from 103 separations.
    Schumm M; Handgretinger R; Pfeiffer M; Feuchtinger T; Kuci S; Faul C; Vogel W; Bethge W; Lang P
    Cytotherapy; 2006; 8(5):465-72. PubMed ID: 17050251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical-grade purification of natural killer cells in haploidentical hematopoietic stem cell transplantation.
    Meyer-Monard S; Passweg J; Siegler U; Kalberer C; Koehl U; Rovó A; Halter J; Stern M; Heim D; Alois Gratwohl JR; Tichelli A
    Transfusion; 2009 Feb; 49(2):362-71. PubMed ID: 19389215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
    Chang YJ; Zhao XY; Huang XJ
    Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cord blood natural killer and lymphokine activated killer lymphocytes following ex vivo cellular engineering.
    Ayello J; van de Ven C; Fortino W; Wade-Harris C; Satwani P; Baxi L; Simpson LL; Sanger W; Pickering D; Kurtzberg J; Cairo MS
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):608-22. PubMed ID: 16737934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.